Compile Data Set for Download or QSAR

Found 270 hits Enz. Inhib. hit(s) with all data for entry = 9219   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450236 (US10676431, Example 1 | US11117861, Example 1) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H21ClF2N4O4S/c1-36(34,35)30-18-5-3-2-4-16(18)17-10-11-20(22(27)21(17)26)31-13-12-19(23(31)32)29-24(33)28-15-8-6-14(25)7-9-15/h2-11,19,30H,12-13H2,1H3,(H2,28,29,33)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.430	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450236 (US10676431, Example 1 | US11117861, Example 1) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H21ClF2N4O4S/c1-36(34,35)30-18-5-3-2-4-16(18)17-10-11-20(22(27)21(17)26)31-13-12-19(23(31)32)29-24(33)28-15-8-6-14(25)7-9-15/h2-11,19,30H,12-13H2,1H3,(H2,28,29,33)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	200	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450237 (US10676431, Example 2 | US11117861, Example 2) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H19ClF3N3O3/c25-14-5-7-18(17(26)11-14)29-24(34)30-19-9-10-31(23(19)33)20-8-6-16(21(27)22(20)28)15-4-2-1-3-13(15)12-32/h1-8,11,19,32H,9-10,12H2,(H2,29,30,34)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	4.20	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450237 (US10676431, Example 2 | US11117861, Example 2) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H19ClF3N3O3/c25-14-5-7-18(17(26)11-14)29-24(34)30-19-9-10-31(23(19)33)20-8-6-16(21(27)22(20)28)15-4-2-1-3-13(15)12-32/h1-8,11,19,32H,9-10,12H2,(H2,29,30,34)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	360	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450238 (US10676431, Example 3 | US11117861, Example 3) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O3/c25-15-5-7-16(8-6-15)28-24(33)29-19-11-12-30(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-31/h1-10,19,31H,11-13H2,(H2,28,29,33)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.10	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450238 (US10676431, Example 3 | US11117861, Example 3) Show SMILES OCc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O3/c25-15-5-7-16(8-6-15)28-24(33)29-19-11-12-30(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-31/h1-10,19,31H,11-13H2,(H2,28,29,33)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	220	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450239 (US10676431, Example 4 | US11117861, Example 4) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3c(F)cc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H19ClF4N4O4S/c1-38(36,37)32-17-5-3-2-4-13(17)14-6-7-19(21(29)20(14)28)33-9-8-18(23(33)34)30-24(35)31-22-15(26)10-12(25)11-16(22)27/h2-7,10-11,18,32H,8-9H2,1H3,(H2,30,31,35)/t18-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.930	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450239 (US10676431, Example 4 | US11117861, Example 4) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3c(F)cc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H19ClF4N4O4S/c1-38(36,37)32-17-5-3-2-4-13(17)14-6-7-19(21(29)20(14)28)33-9-8-18(23(33)34)30-24(35)31-22-15(26)10-12(25)11-16(22)27/h2-7,10-11,18,32H,8-9H2,1H3,(H2,30,31,35)/t18-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.70E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450240 (US10676431, Example 5 | US11117861, Example 5) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF3N4O4S/c1-37(35,36)31-17-5-3-2-4-14(17)15-7-9-20(22(28)21(15)27)32-11-10-19(23(32)33)30-24(34)29-18-8-6-13(25)12-16(18)26/h2-9,12,19,31H,10-11H2,1H3,(H2,29,30,34)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.680	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450240 (US10676431, Example 5 | US11117861, Example 5) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF3N4O4S/c1-37(35,36)31-17-5-3-2-4-14(17)15-7-9-20(22(28)21(15)27)32-11-10-19(23(32)33)30-24(34)29-18-8-6-13(25)12-16(18)26/h2-9,12,19,31H,10-11H2,1H3,(H2,29,30,34)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	230	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450241 (US10676431, Example 6 | US11117861, Example 6) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3)C(F)(F)F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H21F5N4O4S/c1-39(37,38)33-18-5-3-2-4-16(18)17-10-11-20(22(27)21(17)26)34-13-12-19(23(34)35)32-24(36)31-15-8-6-14(7-9-15)25(28,29)30/h2-11,19,33H,12-13H2,1H3,(H2,31,32,36)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450241 (US10676431, Example 6 | US11117861, Example 6) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3)C(F)(F)F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H21F5N4O4S/c1-39(37,38)33-18-5-3-2-4-16(18)17-10-11-20(22(27)21(17)26)34-13-12-19(23(34)35)32-24(36)31-15-8-6-14(7-9-15)25(28,29)30/h2-11,19,33H,12-13H2,1H3,(H2,31,32,36)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	190	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450242 (US10676431, Example 7 | US11117861, Example 7) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H19ClF3N3O4S/c1-36(34,35)20-5-3-2-4-14(20)15-7-9-19(22(28)21(15)27)31-11-10-18(23(31)32)30-24(33)29-17-8-6-13(25)12-16(17)26/h2-9,12,18H,10-11H2,1H3,(H2,29,30,33)/t18-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.10	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450242 (US10676431, Example 7 | US11117861, Example 7) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H19ClF3N3O4S/c1-36(34,35)20-5-3-2-4-14(20)15-7-9-19(22(28)21(15)27)31-11-10-18(23(31)32)30-24(33)29-17-8-6-13(25)12-16(17)26/h2-9,12,18H,10-11H2,1H3,(H2,29,30,33)/t18-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	140	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450243 (US10676431, Example 8 | US11117861, Example 8) Show SMILES Fc1c(F)c(ccc1N1CC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O)-c1ccccc1C#N |r| Show InChI InChI=1S/C24H17ClF2N4O2/c25-15-5-7-16(8-6-15)29-24(33)30-19-11-12-31(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-28/h1-10,19H,11-12H2,(H2,29,30,33)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450243 (US10676431, Example 8 | US11117861, Example 8) Show SMILES Fc1c(F)c(ccc1N1CC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O)-c1ccccc1C#N |r| Show InChI InChI=1S/C24H17ClF2N4O2/c25-15-5-7-16(8-6-15)29-24(33)30-19-11-12-31(23(19)32)20-10-9-18(21(26)22(20)27)17-4-2-1-3-14(17)13-28/h1-10,19H,11-12H2,(H2,29,30,33)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	61	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450245 (US10676431, Example 9 | US11117861, Example 9) Show SMILES Fc1cc(Cl)ccc1NC(=O)N[C@@H]1CCN(C1=O)c1ccc(c(F)c1F)-c1ccccc1C#N |r| Show InChI InChI=1S/C24H16ClF3N4O2/c25-14-5-7-18(17(26)11-14)30-24(34)31-19-9-10-32(23(19)33)20-8-6-16(21(27)22(20)28)15-4-2-1-3-13(15)12-29/h1-8,11,19H,9-10H2,(H2,30,31,34)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.10	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450245 (US10676431, Example 9 | US11117861, Example 9) Show SMILES Fc1cc(Cl)ccc1NC(=O)N[C@@H]1CCN(C1=O)c1ccc(c(F)c1F)-c1ccccc1C#N |r| Show InChI InChI=1S/C24H16ClF3N4O2/c25-14-5-7-18(17(26)11-14)30-24(34)31-19-9-10-32(23(19)33)20-8-6-16(21(27)22(20)28)15-4-2-1-3-13(15)12-29/h1-8,11,19H,9-10H2,(H2,30,31,34)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450246 (US10676431, Example 10 | US11117861, Example 10) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O4S/c1-35(33,34)20-5-3-2-4-16(20)17-10-11-19(22(27)21(17)26)30-13-12-18(23(30)31)29-24(32)28-15-8-6-14(25)7-9-15/h2-11,18H,12-13H2,1H3,(H2,28,29,32)/t18-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.20	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450246 (US10676431, Example 10 | US11117861, Example 10) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C24H20ClF2N3O4S/c1-35(33,34)20-5-3-2-4-16(20)17-10-11-19(22(27)21(17)26)30-13-12-18(23(30)31)29-24(32)28-15-8-6-14(25)7-9-15/h2-11,18H,12-13H2,1H3,(H2,28,29,32)/t18-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	130	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450247 (US10676431, Example 11 | US11117861, Example 11) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3)C(F)(F)F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H20F5N3O4S/c1-38(36,37)20-5-3-2-4-16(20)17-10-11-19(22(27)21(17)26)33-13-12-18(23(33)34)32-24(35)31-15-8-6-14(7-9-15)25(28,29)30/h2-11,18H,12-13H2,1H3,(H2,31,32,35)/t18-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.60	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450247 (US10676431, Example 11 | US11117861, Example 11) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(cc3)C(F)(F)F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H20F5N3O4S/c1-38(36,37)20-5-3-2-4-16(20)17-10-11-19(22(27)21(17)26)33-13-12-18(23(33)34)32-24(35)31-15-8-6-14(7-9-15)25(28,29)30/h2-11,18H,12-13H2,1H3,(H2,31,32,35)/t18-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	290	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450248 (US10676431, Example 12 | US10676431, Example 22 | ...) Show SMILES CC(N)c1cccc(c1)-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H23ClF2N4O2/c1-14(29)15-3-2-4-16(13-15)19-9-10-21(23(28)22(19)27)32-12-11-20(24(32)33)31-25(34)30-18-7-5-17(26)6-8-18/h2-10,13-14,20H,11-12,29H2,1H3,(H2,30,31,34)/t14?,20-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.5	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450248 (US10676431, Example 12 | US10676431, Example 22 | ...) Show SMILES CC(N)c1cccc(c1)-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H23ClF2N4O2/c1-14(29)15-3-2-4-16(13-15)19-9-10-21(23(28)22(19)27)32-12-11-20(24(32)33)31-25(34)30-18-7-5-17(26)6-8-18/h2-10,13-14,20H,11-12,29H2,1H3,(H2,30,31,34)/t14?,20-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	450	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450249 (US10676431, Example 13 | US11117861, Example 13) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ncc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF3N5O4S/c1-37(35,36)31-16-5-3-2-4-13(16)14-6-7-18(20(27)19(14)26)32-9-8-17(22(32)33)29-23(34)30-21-15(25)10-12(24)11-28-21/h2-7,10-11,17,31H,8-9H2,1H3,(H2,28,29,30,34)/t17-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	6.5	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450249 (US10676431, Example 13 | US11117861, Example 13) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ncc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF3N5O4S/c1-37(35,36)31-16-5-3-2-4-13(16)14-6-7-18(20(27)19(14)26)32-9-8-17(22(32)33)29-23(34)30-21-15(25)10-12(24)11-28-21/h2-7,10-11,17,31H,8-9H2,1H3,(H2,28,29,30,34)/t17-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.50E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450250 (US10676431, Example 14 | US11117861, Example 14) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(cc1)N1CC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C25H23F3N4O4S/c1-37(35,36)31-21-5-3-2-4-20(21)16-6-12-19(13-7-16)32-15-14-22(23(32)33)30-24(34)29-18-10-8-17(9-11-18)25(26,27)28/h2-13,22,31H,14-15H2,1H3,(H2,29,30,34)/t22-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	7.20	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450250 (US10676431, Example 14 | US11117861, Example 14) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(cc1)N1CC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C25H23F3N4O4S/c1-37(35,36)31-21-5-3-2-4-20(21)16-6-12-19(13-7-16)32-15-14-22(23(32)33)30-24(34)29-18-10-8-17(9-11-18)25(26,27)28/h2-13,22,31H,14-15H2,1H3,(H2,29,30,34)/t22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	600	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450251 (US10676431, Example 15 | US11117861, Example 15) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3cnc(Cl)cn3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C22H19ClF2N6O4S/c1-36(34,35)30-14-5-3-2-4-12(14)13-6-7-16(20(25)19(13)24)31-9-8-15(21(31)32)28-22(33)29-18-11-26-17(23)10-27-18/h2-7,10-11,15,30H,8-9H2,1H3,(H2,27,28,29,33)/t15-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	10	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450251 (US10676431, Example 15 | US11117861, Example 15) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3cnc(Cl)cn3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C22H19ClF2N6O4S/c1-36(34,35)30-14-5-3-2-4-12(14)13-6-7-16(20(25)19(13)24)31-9-8-15(21(31)32)28-22(33)29-18-11-26-17(23)10-27-18/h2-7,10-11,15,30H,8-9H2,1H3,(H2,27,28,29,33)/t15-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.50E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450252 (US10676431, Example 16 | US11117861, Example 16) Show SMILES Fc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H17ClF3N3O2/c24-13-5-7-14(8-6-13)28-23(32)29-18-11-12-30(22(18)31)19-10-9-16(20(26)21(19)27)15-3-1-2-4-17(15)25/h1-10,18H,11-12H2,(H2,28,29,32)/t18-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	12	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450252 (US10676431, Example 16 | US11117861, Example 16) Show SMILES Fc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H17ClF3N3O2/c24-13-5-7-14(8-6-13)28-23(32)29-18-11-12-30(22(18)31)19-10-9-16(20(26)21(19)27)15-3-1-2-4-17(15)25/h1-10,18H,11-12H2,(H2,28,29,32)/t18-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	120	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450253 (US10676431, Example 17 | US11117861, Example 17) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cn3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H20ClF2N5O4S/c1-36(34,35)30-16-5-3-2-4-14(16)15-7-8-18(21(26)20(15)25)31-11-10-17(22(31)32)28-23(33)29-19-9-6-13(24)12-27-19/h2-9,12,17,30H,10-11H2,1H3,(H2,27,28,29,33)/t17-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	16	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450253 (US10676431, Example 17 | US11117861, Example 17) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cn3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H20ClF2N5O4S/c1-36(34,35)30-16-5-3-2-4-14(16)15-7-8-18(21(26)20(15)25)31-11-10-17(22(31)32)28-23(33)29-19-9-6-13(24)12-27-19/h2-9,12,17,30H,10-11H2,1H3,(H2,27,28,29,33)/t17-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	4.10E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450254 (US10676431, Example 18 | US11117861, Example 18) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3cnc(cn3)C(F)(F)F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19F5N6O4S/c1-39(37,38)33-14-5-3-2-4-12(14)13-6-7-16(20(25)19(13)24)34-9-8-15(21(34)35)31-22(36)32-18-11-29-17(10-30-18)23(26,27)28/h2-7,10-11,15,33H,8-9H2,1H3,(H2,30,31,32,36)/t15-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	20	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450254 (US10676431, Example 18 | US11117861, Example 18) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3cnc(cn3)C(F)(F)F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19F5N6O4S/c1-39(37,38)33-14-5-3-2-4-12(14)13-6-7-16(20(25)19(13)24)34-9-8-15(21(34)35)31-22(36)32-18-11-29-17(10-30-18)23(26,27)28/h2-7,10-11,15,33H,8-9H2,1H3,(H2,30,31,32,36)/t15-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.10E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450255 (US10676431, Example 19 | US11117861, Example 19) Show SMILES Fc1ncccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C22H16ClF3N4O2/c23-12-3-5-13(6-4-12)28-22(32)29-16-9-11-30(21(16)31)17-8-7-14(18(24)19(17)25)15-2-1-10-27-20(15)26/h1-8,10,16H,9,11H2,(H2,28,29,32)/t16-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	22	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450255 (US10676431, Example 19 | US11117861, Example 19) Show SMILES Fc1ncccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C22H16ClF3N4O2/c23-12-3-5-13(6-4-12)28-22(32)29-16-9-11-30(21(16)31)17-8-7-14(18(24)19(17)25)15-2-1-10-27-20(15)26/h1-8,10,16H,9,11H2,(H2,28,29,32)/t16-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	78	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450256 (US10676431, Example 20 | US11117861, Example 20) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(cc1)N1CC[C@@H](NC(=O)Nc2ccc(nc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C24H22F3N5O4S/c1-37(35,36)31-19-5-3-2-4-18(19)15-6-9-17(10-7-15)32-13-12-20(22(32)33)30-23(34)29-16-8-11-21(28-14-16)24(25,26)27/h2-11,14,20,31H,12-13H2,1H3,(H2,29,30,34)/t20-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	24	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450256 (US10676431, Example 20 | US11117861, Example 20) Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(cc1)N1CC[C@@H](NC(=O)Nc2ccc(nc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C24H22F3N5O4S/c1-37(35,36)31-19-5-3-2-4-18(19)15-6-9-17(10-7-15)32-13-12-20(22(32)33)30-23(34)29-16-8-11-21(28-14-16)24(25,26)27/h2-11,14,20,31H,12-13H2,1H3,(H2,29,30,34)/t20-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450257 (US10676431, Example 21 | US11117861, Example 21) Show SMILES Fc1cc(Cl)ccc1NC(=O)N[C@@H]1CCN(C1=O)c1ccc(c(F)c1F)-c1ccccc1F |r| Show InChI InChI=1S/C23H16ClF4N3O2/c24-12-5-7-17(16(26)11-12)29-23(33)30-18-9-10-31(22(18)32)19-8-6-14(20(27)21(19)28)13-3-1-2-4-15(13)25/h1-8,11,18H,9-10H2,(H2,29,30,33)/t18-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450257 (US10676431, Example 21 | US11117861, Example 21) Show SMILES Fc1cc(Cl)ccc1NC(=O)N[C@@H]1CCN(C1=O)c1ccc(c(F)c1F)-c1ccccc1F |r| Show InChI InChI=1S/C23H16ClF4N3O2/c24-12-5-7-17(16(26)11-12)29-23(33)30-18-9-10-31(22(18)32)19-8-6-14(20(27)21(19)28)13-3-1-2-4-15(13)25/h1-8,11,18H,9-10H2,(H2,29,30,33)/t18-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	390	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450248 (US10676431, Example 12 | US10676431, Example 22 | ...) Show SMILES CC(N)c1cccc(c1)-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H23ClF2N4O2/c1-14(29)15-3-2-4-16(13-15)19-9-10-21(23(28)22(19)27)32-12-11-20(24(32)33)31-25(34)30-18-7-5-17(26)6-8-18/h2-10,13-14,20H,11-12,29H2,1H3,(H2,30,31,34)/t14?,20-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	33	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450248 (US10676431, Example 12 | US10676431, Example 22 | ...) Show SMILES CC(N)c1cccc(c1)-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H23ClF2N4O2/c1-14(29)15-3-2-4-16(13-15)19-9-10-21(23(28)22(19)27)32-12-11-20(24(32)33)31-25(34)30-18-7-5-17(26)6-8-18/h2-10,13-14,20H,11-12,29H2,1H3,(H2,30,31,34)/t14?,20-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.50E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450260 (US10676431, Example 23 | US11117861, Example 23) Show SMILES CS(=O)(=O)Nc1ncccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF3N5O4S/c1-37(35,36)31-21-14(3-2-9-28-21)13-5-7-18(20(27)19(13)26)32-10-8-17(22(32)33)30-23(34)29-16-6-4-12(24)11-15(16)25/h2-7,9,11,17H,8,10H2,1H3,(H,28,31)(H2,29,30,34)/t17-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	8.20	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450260 (US10676431, Example 23 | US11117861, Example 23) Show SMILES CS(=O)(=O)Nc1ncccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF3N5O4S/c1-37(35,36)31-21-14(3-2-9-28-21)13-5-7-18(20(27)19(13)26)32-10-8-17(22(32)33)30-23(34)29-16-6-4-12(24)11-15(16)25/h2-7,9,11,17H,8,10H2,1H3,(H,28,31)(H2,29,30,34)/t17-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	700	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450261 (BDBM518762 | US10676431, Example 24) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cn3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF2N4O4S/c1-35(33,34)18-5-3-2-4-14(18)15-7-8-17(21(26)20(15)25)30-11-10-16(22(30)31)28-23(32)29-19-9-6-13(24)12-27-19/h2-9,12,16H,10-11H2,1H3,(H2,27,28,29,32)/t16-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	22	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450261 (BDBM518762 | US10676431, Example 24) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cn3)C2=O)c(F)c1F |r| Show InChI InChI=1S/C23H19ClF2N4O4S/c1-35(33,34)18-5-3-2-4-14(18)15-7-8-17(21(26)20(15)25)30-11-10-16(22(30)31)28-23(32)29-19-9-6-13(24)12-27-19/h2-9,12,16H,10-11H2,1H3,(H2,27,28,29,32)/t16-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.40E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450262 (US10676431, Example 25 | US11117861, Example 25) Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H22ClF3N3O3P/c1-36(2,35)21-6-4-3-5-15(21)16-8-10-20(23(29)22(16)28)32-12-11-19(24(32)33)31-25(34)30-18-9-7-14(26)13-17(18)27/h3-10,13,19H,11-12H2,1-2H3,(H2,30,31,34)/t19-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.530	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450262 (US10676431, Example 25 | US11117861, Example 25) Show SMILES CP(C)(=O)c1ccccc1-c1ccc(N2CC[C@@H](NC(=O)Nc3ccc(Cl)cc3F)C2=O)c(F)c1F |r| Show InChI InChI=1S/C25H22ClF3N3O3P/c1-36(2,35)21-6-4-3-5-15(21)16-8-10-20(23(29)22(16)28)32-12-11-19(24(32)33)31-25(34)30-18-9-7-14(26)13-17(18)27/h3-10,13,19H,11-12H2,1-2H3,(H2,30,31,34)/t19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	260	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 270 total )  |  Next  |  Last  >>

Jump to: